Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer

NCT03473652 | Completed Results

• 1 other identifier: APPAHOCA
• Study Type: interventional
• Target: 45
• Locations: 1 country
• Sites: 2

Brief Summary

The investigator propose to evaluate the interest of the provision of a suitable treadmill offering fall protection and verticalization assistance.

Conditions

Oncology; Adapted Physical Activity

Outcome Measures

Primary Outcomes (1)

• Patient Adherence to Use a Walking Platform

  Adapted physical activity on a walking platform will be considered feasible if \> or = to 70% of patients perform \> or = to 2 sessions of 6 minutes or more during hospitalization for cancer lasting \> or = to 48h

  2 days

Study Arms (1)

Adapted walking platform

OTHER

Other: Adapted walking platform

Interventions

Adapted walking platform OTHER

The walking sessions will be carried out on a suitable walking platform, including a connected play tablet.

Adapted walking platform

Eligibility Criteria

• Age: 70 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Patient with cancer
• Patient over 70 years old hospitalized 48 hours or more
• Patient identified as eligible for medical prescription of Adapted physical activity
• Mastery of the French language ;
• Patient affiliated to a social security scheme
• Patient giving written consent

You may not qualify if:

• Patient totally unable to communicate
• Patient in terminal palliative care
• Patient with a size \<1m35 or\> 2m and / or a weight\> 130kg
• Patient unable to perform Adapted physical activity sessions
• Patient unable to wear a restraint harness.
• Patient deprived of liberty or under guardianship
• Patient unable to comply with protocol requirements for geographical, social or psychopathological reasons

Sponsors & Collaborators

• Centre Francois Baclesse: lead

Study Sites (2)

Centre François Baclesse

Caen, 14000, France

Location

CHU

Caen, 14000, France

Location

MeSH Terms

Conditions

Neoplasms

Results Point of Contact

• Title: Alexandra LECONTE
• Organization: Centre François Baclesse

a.leconte@baclesse.unicancer.fr

0231455002

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 12, 2018
• First Posted: March 22, 2018
• Study Start: May 29, 2018
• Primary Completion: October 11, 2018
• Study Completion: December 11, 2018
• Last Updated: December 15, 2025
• Results First Posted: December 15, 2025

Record last verified: 2025-11

Data Sharing

• IPD Sharing: Will not share

Locations

FR (2)